灵洋品牌怎么样 申请店铺

我要投票 灵洋在医疗器械行业中的票数:308 更新时间:2025-07-22
灵洋是哪个国家的品牌?「灵洋」是 浙江灵洋医疗器械有限公司 旗下著名品牌。该品牌发源于浙江省台州市,由创始人胡军飞在2000-12-25期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力灵洋品牌出海!将品牌入驻外推网,定制灵洋品牌推广信息,可以显著提高灵洋产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

灵洋怎么样

浙江灵洋医疗器械有限公司,坐落在临海市的西部开发区。公司的前身是成立于1987年的临海市医疗器械厂,创办之初即定位于一次性医疗器械的专业制造。

公司总占地面积80亩,总建筑面积5.5万平方米,其中10万级洁净厂房1.6万平方米。现有员工760人,管理人员91人,研发人员39人。

2012年以来,公司结合“医疗器械质量管理规范”的要求,在生产自动化方面加大投入,投资2000多万元,对现有洁净车间进行改造,引进各零部件自动组装机、包装线等国内外全自动生产线,以自动化设备替代手工操作,大大提高生产效率;同时具备全套的检测仪器,为企业的发展提供质量保障。

历年来,公司本着“锐意进取,开拓创新,永无止境”的企业精神,围绕“分秒求创新 点滴显真情”的价值观,专注于科技型、人性化产品的创新活动。通过ISO9001质量体系,ISO14001环境体系和OHSAS18001体系认证,针对每个产品每道工序,公司制定产品生产工艺流程与工艺指导文件,共建立100多个控制文件,生产过程严格执行工艺文件规定,每道工艺经过验证评价后使用。按各产品质量要求制定进货检验、过程控制和出厂检验等规范,并设立90多个生产过程质量控制点。

经过多年的创新与发展,现已成为行业内主导生产一次性输液器类、注射器类和氧疗护理类三大系列产品的企业。先后申请获得16项发明专利和实用新型专利。自主开发组合钢针型输液器、一次性使用低阻力注射器、一次性使用精密过滤输液器、一次性使用组合吸痰管等专利产品。低阻力注射器、组合吸痰管、离子膜精密过滤输液器,不断的技术创新和产品开发成就企业一个又一个亮点,为企业的发展奠定基础。

优质的产品,良好的企业形象,促进公司不断持续地发展,现在灵洋公司集研发、生产、销售于一体,在各地设有几十个分公司和办事处,销售网络覆盖全国。

“灵洋”是一支具有高度凝聚力、创新力和战斗力的团队,正以“海纳百川”的气魄热忱的欢迎四方人才的加盟;以“同甘苦、共荣辱”的协作精神推动灵洋公司向国际化企业集团昂首奋进。


Zhejiang Lingyang Medical Equipment Co., Ltd. is located in the Western Development Zone of Linhai City. The predecessor of the company is Linhai medical device factory, which was founded in 1987. At the beginning of its establishment, it was located in the professional manufacturing of disposable medical devices. The company covers an area of 80 mu, with a total construction area of 55000 square meters, including 16000 square meters of 100000 level clean workshop. At present, there are 760 employees, 91 management personnel and 39 R & D personnel. Since 2012, the company has increased investment in production automation in accordance with the requirements of "medical device quality management standard", invested more than 20 million yuan, renovated the existing clean workshop, introduced automatic assembly machines, packaging lines and other fully automatic production lines at home and abroad, replaced manual operation with automatic equipment, greatly improving production efficiency; at the same time, it has a full set of detectors To provide quality assurance for the development of enterprises. Over the years, based on the enterprise spirit of "forge ahead, develop and innovate, never-ending", focusing on the value of "seeking innovation every minute to show the truth", the company has focused on the innovation activities of technology-based and humanized products. Through ISO9001 quality system, ISO14001 environmental system and OHSAS18001 system certification, the company has developed product production process and process guidance documents for each process of each product, and established more than 100 control documents in total. The production process strictly complies with the requirements of process documents, and each process is used after verification and evaluation. Formulate incoming inspection, process control and delivery inspection specifications according to product quality requirements, and set up more than 90 production process quality control points. After years of innovation and development, it has become a leading manufacturer of three series of products in the industry: disposable infusion sets, syringes and oxygen therapy nursing. It has applied for 16 invention patents and utility model patents. Independent development of combination of steel needle infusion set, disposable low resistance syringe, disposable precision filter infusion set, disposable combination suction tube and other patented products. Low resistance syringe, combined suction tube, ion-exchange membrane precision filtration infusion set, continuous technological innovation and product development have made the enterprise one by one bright spot, laying the foundation for the development of the enterprise. High quality products and good corporate image promote the continuous development of the company. Now Lingyang company integrates R & D, production and sales. It has dozens of branches and offices all over the country, with sales network covering the whole country. "Lingyang" is a team with high cohesion, innovation and combat effectiveness. With the spirit of "embracing all rivers and seas", we warmly welcome the talents from all over the world to join us. With the spirit of "sharing weal and woe, sharing honor and Disgrace", we are pushing Lingyang company forward to an international enterprise group.

本文链接: https://brand.waitui.com/c74a5fb5e.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

LPR“按兵不动”,后续仍有下行空间

7月21日,中国人民银行授权全国银行间同业拆借中心公布新一期贷款市场报价利率(LPR),1年期为3.0%,5年期以上为3.5%,均与上期持平。业内专家表示,本月LPR维持不变符合市场预期。在大力提振内需等因素下,后续LPR仍有下行空间。(中证网)

55分钟前

阿里通义千问宣布更新旗舰版Qwen3模型

阿里通义千问宣布更新旗舰版Qwen3模型,推出Qwen3-235B-A22B-FP8非思考模式(Non-thinking)的更新版本,命名为Qwen3-235B-A22B-Instruct-2507-FP8。本次更新的Qwen3模型,长文本提升到256K。目前,Qwen3新模型已在魔搭社区和HuggingFace上开源更新。(第一财经)

55分钟前

优必选:拟折让约9.14%配售新H股,净筹约24.10亿港元

36氪获悉,优必选公告,于2025年7月22日(联交所交易时段前),公司与配售代理订立配售协议,据此,公司已同意委任配售代理,而配售代理已同意按尽力基准,个别(但非共同或共同及个别)作为公司的代理,促使认购方按配售价认购合共3015.5450万股新H股。配售价为每股82.00港元,较于2025年7月21日在联交所所报收市价折让约9.14%。经扣除相关费用及开支,公司将自配售事项收取的所得款项总额及所得款项净额估计分别约为24.7275亿港元及24.1026亿港元。

55分钟前

公募基金集中重仓行业龙头个股,对核心资产长期信心不变

Wind数据显示,二季度多只行业龙头个股获得公募基金集中配置,从行业所属分类来看,制造业和消费资产成为配置核心;信息技术行业持仓显著提升,反映出对科技创新类标的的乐观预期。分析人士认为,当前中国经济稳步向好,龙头企业受益于产业升级和消费升级趋势,支撑其盈利稳定性;市场表现上,A股核心资产具有高流动性和低波动性特征,吸引避险资金流入,加之政策和监管环境持续优化,如鼓励科技创新和消费提振,增强投资者对龙头股的配置意愿;行业和板块配置方面,基金偏好高ROE和稳定分红的资产,以平衡组合风险。(证券日报)

55分钟前

华泰证券:乳制品行业2026年有望迎来供需拐点

36氪获悉,华泰证券研报表示,中国奶业周期正处于奶价低迷带动上游养殖业持续去产能、下游乳品企业渠道库存去化到位、静待终端需求复苏的基本面左侧,预计在原奶产量下降及乳制品终端需求温和改善的供需关系重塑下,行业有望2026年重回供需平衡,届时原奶价格上涨将对上游牧业企业的利润和股价形成直接催化;因乳品产业链市值大幅集中于下游乳制品企业,历史周期表明奶价温和上涨利于下游企业毛销差改善和利润率提升,目前两大龙头也默契进入提升利润诉求阶段。

55分钟前

本页详细列出关于灵洋的品牌信息,含品牌所属公司介绍,灵洋所处行业的品牌地位及优势。
咨询